Skip to main
TVTX

Travere Therapeutics (TVTX) Market Capitalization Overview

Market Cap: $3.54B as of Jan 2, 2026

$3.54B
$417.84M (13.40%)past month
As of Jan 2, 2026, Travere Therapeutics (TVTX) has a market capitalization of $3.54B. Over the past 30 days, its market cap has increased by 12.3%, while in the last 12 months, it has increased by 3.43%.

Market capitalization represents the total value of Travere Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Travere Therapeutics (TVTX) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Travere Therapeutics (TVTX) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Travere Therapeutics (TVTX) Market Cap History

DateMarket CapChange
Dec 1, 2025$3.15B+1.91%
Nov 3, 2025$3.09B+39.81%
Oct 1, 2025$2.21B+36.58%
Sep 2, 2025$1.62B+16.56%
Aug 1, 2025$1.39B+6.25%
Jul 1, 2025$1.31B-5.22%
Jun 2, 2025$1.38B-25.21%
May 1, 2025$1.85B+19.08%
Apr 1, 2025$1.55B-11.92%
Mar 3, 2025$1.76B-0.16%
Feb 3, 2025$1.76B+6.59%
Jan 2, 2025$1.66B-3.07%

Travere Therapeutics (TVTX) End of Year Market Cap History

DateMarket CapChange
2026$3.54B+3.43%
2025$3.42B+125.49%
2024$1.52B+124.43%
2023$675.57M-49.94%
2022$1.35B-28.99%
2021$1.91B

FAQs About Travere Therapeutics (TVTX) Market Cap

As of Jan 2, 2026, the market capitalization of Travere Therapeutics (TVTX) is $3.54B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Travere Therapeutics’s market capitalization has increased by 13.40%, changing from $3.12B to $3.54B as of Jan 2, 2026.

In the last 3 months, Travere Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Travere Therapeutics’s market capitalization increased from $1.52B in January to $3.42B in December, reflecting a 125.49% change.

In the past five years, Travere Therapeutics (TVTX) has had a compound annual growth rate (CAGR) of 12.46% in market capitalization. This means its market cap has grown at an average rate of 12.46% per year.

Travere Therapeutics (TVTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.